Related Experiment Video

Updated: May 11, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

Immunotherapeutic approaches in triple-negative breast cancer: latest research and clinical prospects

John Stagg1, Bertrand Allard

  • 1Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Faculté de Pharmacie et Institut du Cancer de Montréal, Montréal, Québec, Canada H2L 4M1.

Therapeutic Advances in Medical Oncology
|May 2, 2013
PubMed

Insights

Triple-negative breast cancer (TNBC) shows poor prognosis due to lack of molecular targets. Tumor-infiltrating immune cells and novel immunotherapies offer potential treatment avenues for TNBC patients.

Area of Science:

  • Oncology
  • Immunology

Background:

  • Triple-negative breast cancer (TNBC) lacks specific molecular targets, presenting a significant clinical challenge.
  • TNBC is characterized by the absence of estrogen receptors, progesterone receptors, and HER2 expression.
  • Recent genomic studies reveal the molecular heterogeneity of TNBC.

Purpose of the Study:

  • To review the impact of tumor-infiltrating immune cells on TNBC clinical outcomes.
  • To discuss newly identified tumor-associated antigens in TNBC.
  • To summarize promising immunotherapeutic strategies for TNBC.

Main Methods:

  • Literature review of scientific evidence on TNBC and immunotherapy.
  • Analysis of studies investigating tumor-infiltrating lymphocytes and tumor-associated antigens.
  • Overview of current and emerging immunotherapies for TNBC.

Main Results:

  • Clinical outcomes in TNBC are influenced by tumor-infiltrating immune cells.
  • Specific tumor-associated antigens have been identified in TNBC.
  • Various immunotherapies, including vaccines, immune-checkpoint inhibitors, and adoptive cell therapies, show promise.

Conclusions:

  • Selected TNBC patients with lymphocytic infiltrates may benefit from immunotherapy.
  • Combination therapies, particularly immunotherapy with cytotoxic drugs, may enhance anti-tumor immunity.
  • Further research into immune-based strategies is crucial for advancing TNBC treatment.
Keywords:
T cellbasal likebreast cancerimmunotherapy

More Related Videos

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...